Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NF-κB p65 in LPS signaling pathway

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 499-507

  Furusawa, Jun ichi ^a   Funakoshi Tago, Megumi ^a   Mashino, Tadahiko ^a   Tago, Kenji ^b   Inoue, Hideo ^c   Sonoda, Yoshiko ^a   Kasahara, Tadashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b Graduate School of Biological Sciences   (Japan)

^c Minophagen Pharmaceutical Co Ltd   (Japan)

Author keywords

Glycyrrhiza inflata; Licochalcone A; Licochalcone B; Licochalcone D; LPS; NF B

Indexed keywords

CHALCONE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ECHINATIN; I KAPPA B; ISOLIQUIRITIGENIN; LICOCHALCONE A; LICOCHALCONE B; LICOCHALCONE C; LICOCHALCONE D; LIPOPOLYSACCHARIDE; LUCIFERASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHEMICAL COMPOSITION; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; GLYCYRRHIZA; GLYCYRRHIZA INFLATA; IMMUNOBLOTTING; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH ULCER; TRADITIONAL MEDICINE; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; CHALCONES; CHEMOKINE CCL2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLYCYRRHIZA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PYRROLIZIDINE ALKALOIDS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61649115375     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.031     Document Type: Article

References (41)

1. Morson B.C. Pathology of inflammatory diseases. Proc R Soc Med 63 (1970) 63 Suppl
2. Brown K.L., Cosseau C., Gardy J.L., and Hancock R.E. Complexities of targeting innate immunity to treat infection. Trends Immunol 28 (2007) 260-266
3. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
4. Ziegler-Heitbrock H.W. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45 (1995) 13-26
5. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23 (2001) 99-109
6. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
7. Müller J.M., Ziegler-Heitbrock H.W., and Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187 (1993) 233-256
8. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
9. Xie Q.W., Whisnant R., and Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177 (1993) 1779-1784
10. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., and Jongeneel C.V. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171 (1990) 35-47
11. Legrand-Poels S., Maniglia S., Boelaert J.R., and Piette J. Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells. Biochem Pharmacol 53 (1997) 339-346
12. Ueno M., Sonoda Y., Funakoshi M., Mukaida N., Nose K., and Kasahara T. Differential induction of JE/MCP-1 in subclones from a murine macrophage cell line, RAW 264.7: role of kappaB-3 binding protein. Cytokine 12 (2000) 207-219
13. Doyle S.L., and O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72 (2006) 1102-1113
14. Kawai T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
15. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 (1999) 10689-10692
16. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
17. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91 (1997) 243-252
18. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
19. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93 (1998) 1231-1240
20. Westenberger U., Thanner S., Ruf H.H., Gersonde K., Sutter G., and Trentz O. Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Radic Res Commun 11 (1990) 167-178
21. Buckley J.M., Wang J.H., and Redmond H.P. Cellular reprogramming by gram-positive bacterial components: a review. J Leukoc Biol 80 (2006) 731-741
22. Galanos C., and Freudenberg M.A. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187 (1993) 346-356
23. Downey J.S., and Han J. Cellular activation mechanisms in septic shock. Front Biosci 3 (1998) d468-d476
24. Hatano T., Kagawa H., Yasuhara T., and Okuda T. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chem Pharm Bull 36 (1988) 2090-2097
25. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120 (2000) 849-862
26. Furusawa J, Funakoshi-Tago M, Tago K, Mashino T, Inoue H, Sonoda Y, et al. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-κB p65 phosphorylation at serine 276. Cell Signal. (in press).
27. Funakoshi-Tago M., Tago K., Nishizawa C., Takahashi K., Mashino T., Iwata S., et al. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation. Biochem Pharmacol (Sep 19 2008)
28. Oda T., Kasahara T., Matsuura M., and Mukaida N. Nitric oxide-mediated modulation of interleukin-8 production by a human glioblastoma cell line, T98G, cocultured with myeloid and monocytic cell lines. J Interferon Cytokine Res 18 (1998) 905-912
29. Funakoshi-Tago M., Sonoda Y., Tanaka S., Hashimoto K., Tago K., Tominaga S., et al. Tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts. J Biol Chem 278 (2003) 29359-29365
30. Zhong H., Voll R.E., and Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1 (1998) 661-671
31. Sakurai H., Chiba H., Miyoshi H., Sugita T., and Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274 (1999) 30353-30356
32. Wijayanti N., Naidu S., Kietzmann T., and Immenschuh S. Inhibition of phorbol ester-dependent peroxiredoxin I gene activation by lipopolysaccharide via phosphorylation of RelA/p65 at serine 276 in monocytes. Free Radic Biol Med 44 (2008) 699-710
33. Dong J., Jimi E., Zhong H., Hayden M.S., and Ghosh S. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 22 (2008) 1159-1173
34. Lee J.C., and Young P.R. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59 (1996) 152-157
35. Haraguchi H., Ishikawa H., Mizutani K., Tamura Y., and Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6 (1998) 339-347
36. Chen M., Christensen S.B., Blom J., Lemmich E., Nadelmann L., Fich K., et al. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob Agents Chemother 37 (1993) 2550-2556
37. Fukai T., Marumo A., Kaitou K., Kanda T., Terada S., and Nomura T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 71 (2002) 1449-1463
38. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., and Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97 (2000) 3919-3924
39. Almawi W.Y., and Melemedjian O.K. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71 (2002) 9-15
40. Kim J.Y., Park S.J., Yun K.J., Cho Y.W., Park H.J., and Lee K.T. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol 584 (2008) 175-184
41. Wang B.H., Lu Z.X., and Polya G.M. Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med 64 (1998) 195-199